Back to search
FDAFDA · Food and drugs·Recall number D-0868-2017

Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 count bottles, Rx Only, Manufactured in Austria by Sandoz Gmbh for Sandoz Inc. Princeton NJ NDC 0781-1831-20

Published June 7, 2017 · Recall initiated: April 26, 2017

Summary

FDA records drug Class III recall D-0868-2017, published June 7, 2017 and initiated April 26, 2017. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 4,464 bottles; Lot: Lot FP8735, 8/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug; Clavulanic Acid

What to do

Voluntary: Firm initiated · Letter

Get an email if AMOXICILLIN AND CLAVULANATE POTASSIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
AMOXICILLIN AND CLAVULANATE POTASSIUM
Manufacturer
Sandoz Inc
Distributor
NY, OH
UPC
0307816102462
Lot
Lot FP8735, 8/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 count bottles, Rx Only, Manufactured in Austria by Sandoz Gmbh for Sandoz Inc. Princeton NJ NDC 0781-1831-20 recalled?

Yes. FDA published recall D-0868-2017 on June 7, 2017. Reported hazard: Subpotent Drug; Clavulanic Acid

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: AMOXICILLIN AND CLAVULANATE POTASSIUM. UPC: 0307816102462.